Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study
Status:
Withdrawn
Trial end date:
2017-06-07
Target enrollment:
Participant gender:
Summary
To validate on the mid-term in moderate and severe renal failure (CKD 3-4) a nomogram to
adapt a fixed metformin daily posology according to renal function on the basis of the first
short-term study made by the investigators.